Document Detail


Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn.
MedLine Citation:
PMID:  22198909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the pulmonary vasculature, cGMP levels are regulated by soluble guanylate cyclase (sGC) and phosphodiesterase 5 (PDE5). We previously reported that lambs with persistent pulmonary hypertension of the newborn (PPHN) demonstrate increased reactive oxygen species (ROS) and altered sGC and PDE5 activity, with resultant decreased cGMP. The objective of this study was to evaluate the effects of hydrocortisone on pulmonary vascular function, ROS, and cGMP in the ovine ductal ligation model of PPHN. PPHN lambs were ventilated with 100% O(2) for 24 h. Six lambs received 5 mg/kg hydrocortisone every 8 h times three doses (PPHN-hiHC), five lambs received 3 mg/kg hydrocortisone followed by 1 mg·kg(-1)·dose(-1) times two doses (PPHN-loHC), and six lambs were ventilated with O(2) alone (PPHN). All groups were compared with healthy 1-day spontaneously breathing lambs (1DSB). O(2) ventilation of PPHN lambs decreased sGC activity, increased PDE5 activity, and increased ROS vs. 1DSB lambs. Both hydrocortisone doses significantly improved arterial-to-alveolar ratios relative to PPHN lambs, decreased PDE5 activity, and increased cGMP relative to PPHN lambs. High-dose hydrocortisone also increased sGC activity, decreased PDE5 expression, decreased ROS, and increased total vascular SOD activity vs. PPHN lambs. These data suggest that hydrocortisone treatment in clinically relevant doses improves oxygenation and decreases hyperoxia-induced changes in sGC and PDE5 activity, increasing cGMP levels. Hydrocortisone reduces ROS levels in part by increasing SOD activity in PPHN lambs ventilated with 100% O(2.) We speculate that hydrocortisone increases cGMP by direct effects on sGC and PDE5 expression and by attenuating abnormalities induced by oxidant stress.
Authors:
Marta Perez; Satyan Lakshminrusimha; Stephen Wedgwood; Lyubov Czech; Sylvia F Gugino; James A Russell; Kathryn N Farrow; Robin H Steinhorn
Related Documents :
21410079 - The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd re...
21751269 - Evaluation of systemic and dermal toxicity and dermal photoprotection by sour cherry ke...
21797809 - Dna double-strand breaks induced by mammographic screening procedures in human mammary ...
2535799 - Physiologic and plasma hormone correlates of survival in endotoxic dogs: effects of opi...
21793769 - Cervical ripening with foley balloon plus fixed versus incremental low-dose oxytocin: a...
21959809 - Anti-hyperglycemic and antinociceptive activity of methanol leaf and stem extract of ny...
21410079 - The dual therapy with 4 times daily dosing of rabeprazole and amoxicillin as the 3rd re...
18383789 - Mirazid in treatment of human hymenolepiasis.
8452269 - Plasma laudanosine levels in patients given atracurium during liver transplantation.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-12-23
Journal Detail:
Title:  American journal of physiology. Lung cellular and molecular physiology     Volume:  302     ISSN:  1522-1504     ISO Abbreviation:  Am. J. Physiol. Lung Cell Mol. Physiol.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-16     Completed Date:  2012-07-16     Revised Date:  2013-05-22    
Medline Journal Info:
Nlm Unique ID:  100901229     Medline TA:  Am J Physiol Lung Cell Mol Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  L595-603     Citation Subset:  IM    
Affiliation:
Northwestern University, Chicago, Illinois, USA. mtperez@childrensmemorial.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Newborn
Cyclic GMP / metabolism*
Cyclic Nucleotide Phosphodiesterases, Type 5 / genetics,  metabolism
Guanylate Cyclase / metabolism
Humans
Hydrocortisone / pharmacology*
Hyperoxia / drug therapy,  genetics,  metabolism,  physiopathology
Infant, Newborn
Oxidative Stress / drug effects,  genetics
Oxygen / metabolism*
Persistent Fetal Circulation Syndrome / drug therapy*,  genetics,  metabolism*,  physiopathology
Pulmonary Artery / drug effects*,  metabolism,  physiopathology
Reactive Oxygen Species / metabolism
Receptors, Cytoplasmic and Nuclear / metabolism
Sheep
Superoxide Dismutase / metabolism
Grant Support
ID/Acronym/Agency:
HL-086715/HL/NHLBI NIH HHS; HL-54705/HL/NHLBI NIH HHS; K08 HL086715/HL/NHLBI NIH HHS; R01 HL054705/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Reactive Oxygen Species; 0/Receptors, Cytoplasmic and Nuclear; 50-23-7/Hydrocortisone; 7665-99-8/Cyclic GMP; 7782-44-7/Oxygen; EC 1.15.1.1/Superoxide Dismutase; EC 3.1.4.35/Cyclic Nucleotide Phosphodiesterases, Type 5; EC 4.6.1.2/Guanylate Cyclase; EC 4.6.1.2/soluble guanylyl cyclase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn...
Next Document:  Applications of PET-CT in patients with esophageal cancer.